Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia.

This research was supported by the IZKF grant (B-334). As well, we thank Patricia Maiso Laboratory (Marta Lasa and Sarai Sarvide) for providing HS-5 cell line and the protocol for co-culturing mesenchymal stromal cells and tumor cells.